Aignostics launches HETA Clinical for pathology workflows
Oct 16, 2026
Biotech
Aignostics and PanCAN Collaborate on AI Spatial Profiling for Pancreatic Cancer Research
Jun 10, 2026
Aignostics has partnered with the Pancreatic Cancer Action Network to provide AI spatial profiling data for one of the largest pancreatic cancer datasets to date, making outputs freely available to researchers through PanCAN's SPARK platform.
Aignostics has partnered with the Pancreatic Cancer Action Network to expand access to spatial profiling data for pancreatic cancer research, announced in a press release. The collaboration will generate and share AI derived spatial readouts for one of the largest pancreatic cancer datasets assembled to date.
Aignostics will analyze pathology images from PanCAN's SPARK data platform using its Atlas H&E-TME application, which performs tissue quality control, cell classification, and tissue segmentation. The system produces more than 4,500 quantitative readouts per image, powered by Aignostics' pathology foundation model.
The resulting data will be accessible to academic researchers at no cost through SPARK, alongside molecular, clinical, and imaging information from over 1,400 pancreatic cancer patients. Life sciences companies will be able to license the outputs for commercial use. The partnership aims to provide researchers with detailed spatial data to better understand tumor biology and support new therapeutic discoveries.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Enterprise AI Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Enterprise
Nov 13 ETR survey: Claude leads enterprise AI tools on satisfaction and spending plans Nov 13 Peter Sarlin's PostScriptum takes majority stake in Finnish AI deployment firm Brillian Nov 13 Gondola says Codex lifted engineering output 25% as revenue more than doubled Nov 13 DuPont teams with Microsoft and NobleAI to speed up R&D with AI Nov 13 Korean AI startups fear Huang exit could delay planned NVIDIA investmentsMore from Life Sciences
Nov 13 Bracco and Avicenna.AI win FDA clearance for AI that flags brain aneurysms on CT scans Nov 13 Zus Health raises $33 million to build the data layer for healthcare AI Nov 13 Google DeepMind releases AlphaGenome 2 to predict DNA variant effects in specific cell types Nov 13 Taiwan hospital accelerator T+ MedIC names AI ECG and CT screening tools as first winners Nov 13 Sheinbaum meets OpenAI president Greg Brockman on AI in Mexican healthcareFree newsletter
Enterprise AI Brief
Weekly report on AI business applications, enterprise software releases, automation tools, and industry implementations.
Market report
.png)
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
Cancer researchers start testing AURORA AI co-scientists built at Harvard
Nov 06, 2026
Healthcare
HistoIndex and A*STAR Partner on Fibrosis Drug Evaluation
Oct 19, 2026
Biotech
Sophont launches Holon-S1 to predict gene activity from pathology slides
Oct 20, 2026
Healthcare
Brainomix and Pulmonary Fibrosis Foundation Partner on AI Lung Imaging Research
Oct 14, 2026
Healthcare
Penn's Percival AI Flags Hidden Disease Signals in Routine CT Scans
Oct 20, 2026
Healthcare
Free, six days a week
Daily AI Brief: the AI news that matters, in your inbox.